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Abstract: Depression is a recurrent disorder, with about 50% of patients experiencing relapse. 
Exposure to stressful events may have an adverse impact on the long-term course of the disorder 
and may alter the response to a subsequent stressor. Indeed, not all the systems impaired by stress 
may normalize during symptoms remission, facilitating the relapse to the pathology. Hence, we 
investigated the long-lasting effects of chronic restraint stress (CRS) and its influence on the 
modifications induced by the exposure to a second hit on brain-derived neurotrophic factor (BDNF) 
signaling in the prefrontal cortex (PFC). We exposed adult male Sprague Dawley rats to 4 weeks of 
CRS, we left them undisturbed for the subsequent 3 weeks, and then we exposed animals to one 
hour of acute restraint stress (ARS). We found that CRS influenced the release of corticosterone 
induced by ARS and inhibited the ability of ARS to activate mature BDNF, its receptor Tropomyosin 
receptor kinase B (TRKB), and their associated intracellular cascades: the TRKB-PI3K-AKT), the 
MEK-MAPK/ERK, and the Phospholipase C γ (PLCγ) pathways, positively modulated by ARS in 
non-stressed animals. These results suggest that CRS induces protracted and detrimental 
consequences that interfere with the ability of PFC to cope with a challenging situation. 
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1. Introduction 
Depression is a severe and highly diffuse disease affecting more than 10% of the general 
population, and by 2030, it is estimated to become the second leading cause of disability and the 
largest contributor to disease burden [1].  
It has been largely characterized as a recurrent disorder, with approximately 50% of patients 
experiencing relapse [2]. Indeed, most of the remitted patients undergo recurrent episodes of 
depression in the 15 years after the first event of the pathology, with a persistence of residual 
symptoms [3,4]. 
Stress has been widely described as an environmental factor able to induce psychopathologies 
and, in particular, the depressive phenotype [5], and much work in animal modeling has relied on 
the observation that stress is a potent risk factor for the development of several psychiatric disorders. 
The effects of stress may depend on the intensity and duration of the adverse experience [6], as well 
as on the period of life when it begins. Indeed, negative life events occurring early in life may impact 
brain functioning and are critical for later psychopathologies [7], whereas the effect of stress in 
adulthood may have persistent consequences but may also recover physiologically through the 
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activation of dynamic processes that help the brain to achieve successful adaptation [8]. However, 
limited information is available on the long-lasting impacts of stress exposure during adult life, as 
well as on the mechanisms that may promote or prevent relapse. 
Moreover, it has been proved that exposure to stressful events may alter the response to 
subsequent stressors [9] possibly because not all the systems impaired by stress are restored during 
the remission, thus leaving ‘scars’ of vulnerability that may facilitate the relapse to the pathology. 
Brain-derived neurotrophic factor (BDNF) is the most highly diffuse neurotrophin in the brain 
where it is involved in synaptic plasticity, as well as in neuronal function and survival during 
adulthood [10]. One of the hypotheses of depression proposes a role for BDNF in the etiology of the 
pathology [11,12], and it has been demonstrated that depressed patients have lower BDNF levels both 
in serum [13] and in the prefrontal cortex (PFC) and hippocampus (Hip) [14–16] with respect to 
healthy subjects. Accordingly, animal models useful for the study of stress-related disorders show a 
remarkable reduction in the neurotrophin mainly in the PFC and Hip [17–19]. 
The main purpose of this experiment was to investigate if and how stress-induced changes may 
persist beyond chronic stress exposure. To address this objective, we exposed adult male rats to four 
weeks of chronic restraint stress (CRS) and we left them undisturbed for the subsequent three weeks. 
After the period of washout, the animals were exposed to an acute restraint stress (ARS) in order to 
establish differences in responsiveness to the stressful event and to identify the long-lasting 
functional abnormalities that may render them more vulnerable to a challenging precipitating 
condition in the rest period. 
At the molecular level, we aimed to clarify whether CRS may induce long-lasting changes in 
BDNF signaling and if the negative effect of stress may interfere with the ability to react with the 
subsequent ARS in terms of neuroplastic mechanisms. The analyses are focused on the PFC, the brain 
region involved in the stress response [20], characterized by low levels of BDNF in depressed patients 
[21] and known to be properly activated in terms of the markers of neuroplasticity in the timing of 
one hour after an ARS [22] 
2. Results 
2.1. Chronic Restraint Stress Induced Cognitive Impairment in Adult Male Rats 
Exposure to 4 weeks of CRS induced a cognitive impairment as assessed by the novel object 
recognition (NOR) test. Indeed, as previously observed [23,24], we found a significant decrease in the 
NOR discrimination index in all the rats exposed to chronic stress (−32%, p < 0.05 vs. No stress, T 
value = 2.446) in comparison to non-stressed animals (Figure S1). 
2.2. Chronic Restraint Stress Inhibited the Release of Corticosterone Levels Following the Acute Restraint 
Stress 
We then assessed the hypothalamic pituitary adrenal (HPA) axis responsivity to an acute 
challenge by measuring the corticosterone (CORT) plasma levels. As expected, the ARS induced an 
increase in CORT levels in non-stressed animals (+55%, p < 0.05 vs. No stress/No ARS, Fisher’s 
protected least significance difference (PLSD)), an effect that was completely blunted in animals 
previously exposed to CRS, as revealed by the significant CRSxARS interaction (F1-38 = 4.836, p < 0.05, 
two-way ANOVA) (Figure 1). 
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Figure 1. Analysis of corticosterone plasma levels in chronic restraint stress (CRS) rats exposed to an 
acute challenge (acute restraint stress (ARS)) after 3 weeks of washout (wash). The data are the mean 
± SEM. *p < 0.05 vs. No stress/No ARS (two-way ANOVA with PLSD). 
2.3. Chronic Stress Pre-exposure did not Interfere with the Immediate-early Genes Expression Following an 
Acute Restraint Stress 
To evaluate if stress pre-exposure may alter the ability to respond to a challenging 
environmental stimulus, also after 3 weeks of rest from CRS, we investigated the expression of the 
immediate early genes (IEGs) Arc, cFos, and Gadd45β. 
As shown in Figure 2, we found a significant effect of CRS (Arc: F1-38 = 6.872, p < 0.05; cFos: F1-39 = 
9.536, p < 0.01; Gadd45β: F1-40 = 27.992, p < 0.001, two-way ANOVA) and of the ARS (Arc:F1-38 = 39.340, 
p < 0.001; cFos: F1-39 = 10.050, p < 0.01; Gadd45β: F1-40 = 26.904, p < 0.001, two-way ANOVA) on the IEGs 
expression. Indeed, we found a significant decrease in their mRNA levels in stressed animals after 
three weeks of washout (Arc: −39%, p < 0.05; cFos: −62%, p < 0.05; Gadd45β: −36%, p < 0.01 vs. No 
stress/No ARS, Fisher’s PLSD) in comparison to control animals. Moreover, independently from 
stress pre-exposure, the acute challenge induced a significant up-regulation in their gene expression 
in both non-stressed (Arc: +74%, p < 0.001; cFos: +63%, p < 0.01; Gadd45β: +51%, p < 0.001 vs. No 
stress/No ARS, Fisher’s PLSD) and stressed animals (Arc: +138%, p < 0.001; cFos: +167%, p < 0.05; 
Gadd45β: +55%, p < 0.01 vs. CRS + washout/No ARS, Fisher’s PLSD). 
 
Figure 2. Analysis of Arc (panel a), cFos (panel b), and Gadd45β (panel c): mRNA levels in the 
prefrontal cortex of chronically stressed rats (CRS) exposed to an acute challenge (ARS) after 3 weeks 
of washout (wash). The data, expressed as a percent change of No stress/No ARS animals, are the 
mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs. No stress/No ARS ; # p < 0.05, ## p < 0.01, ### p < 0.001 
vs. CRS + washout/No ARS (two-way ANOVA with PLSD). 
2.4. Chronic Stress Interfered with BDNF Signaling Following a Second Hit 
In order to investigate whether stress-pre exposure may influence the activation of mature BDNF 
(mBDNF) signaling following a second hit, we measured the protein expression of the neurotrophin 
BDNF, of its high-affinity receptor TRKB, and their associated intracellular signaling cascades: The 
TRKB-PI3K-AKT, the MEK-MAPK/ERK, and the PLCγ pathways [25]. 
In the crude synaptosomal fraction, we observed a significant CRSxARS interaction (F1-19 = 7.535, 
p < 0.05, two-way ANOVA), with mBDNF protein levels being upregulated by the acute stress 
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specifically in non-stressed animals (+49%, p < 0.01 vs. No stress/No ARS, Fisher’s PLSD) (Figure 3b), 
an effect that was paralleled by a trend of increase in the neurotrophin in the whole homogenate 
(+52%, p = 0.056 vs. No stress/No ARS, Fisher’s PLSD) (Figure 3a). Accordingly, as shown in Figure 
3c, the restraint stress induced an increase in the phosphorylated form of the TRKB receptor in the 
Tyr706 (+57%, p < 0.05 vs. No stress/No ARS, Fisher’s PLSD) (CRSxARS interaction F1-20 = 4.687, p < 
0.05, two-way ANOVA), an effect that was completely paralleled by the upregulation of the TRKB 
full-length form in control animals (+121%, p < 0.01 vs. No stress/No ARS, Fisher’s PLSD) but not in 
animals previously exposed to CRS (Figure 3d), whereas we did not observe any modulation for the 
truncated form of the receptor (Figure 3e). By contrast, in the whole homogenate (Table 1), we did 
not find a statistically significant effect for the CRS nor for the ARS on TRKB protein levels. 
Table 1. Analysis of TRKB receptor (full-length and truncated form) protein levels in the whole 
homogenate of the prefrontal cortex of chronically stressed rats (CRS) exposed to an acute challenge 
(ARS) after 3 weeks of washout (wash). The data, expressed as a percent change of No stress/No ARS 
animals, are the mean ± SEM. 
 No Stress/No ARS No Stress/ARS CRS/No ARS CRS/ARS 
TRKB fl 100 ± 9 78 ± 17 117 ± 10 91 ± 18 
TRKB tr 100 ± 14 79 ± 19 103 ± 7 77 ± 9 
 
Figure 3. Analysis of mature brain-derived neurotrophic factor (mBDNF) (panels a,b) and TRKB 
receptor (phosphorylated, full-length and truncated form) (panels c,d,e) protein levels in the 
prefrontal cortex of chronically stressed rats (CRS) exposed to an acute challenge (ARS) after 3 weeks 
of washout (wash). The data, expressed as a percent change of No stress/No ARS animals, are the 
mean ± SEM. * p<0.05, **p < 0.01 vs. No stress/No ARS (two-way ANOVA with PLSD). 
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Regarding the TRKB-PI3K-AKT pathway, we observed, in the crude synaptosomal fraction, a 
significant effect of CRS (F1-17 = 7.836, p < 0.05, two-way ANOVA) and ARS (F1-17 = 8.168, p < 0.05, two-
way ANOVA) on pAKT Ser473. Indeed, the pre-exposure to CRS induced an increase in its protein 
levels in naïve animals (+33%, p < 0.05 vs. No stress/No ARS, Fisher’s PLSD) (Figure 4a), whereas the 
acute challenge upregulated pAKT Ser473 expression only in non-stressed animals (+34%, p < 0.05 vs. 
No stress/No ARS, Fisher’s PLSD). 
Accordingly, the phosphorylated form of one of the downstream effectors of AKT, pS6 
Ser240/244, was significantly increased by the restraint stress in non-stressed animals (+73%, p < 0.05 
vs. No stress/No ARS, Fisher’s PLSD), with an ARS effect (F1-24 = 6.329, p < 0.05, two-way ANOVA) 
(Figure 4c). However, the total forms of both AKT and S6 (Figure 4b–d respectively) were neither 
significantly modulated by CRS nor by ARS. 
 
Figure 4. Analysis of AKT (panels a,b) and S6 (panels c,d) (phosphorylated and total) protein levels 
in the crude synaptosomal fraction of the prefrontal cortex of chronically stressed rats (CRS) exposed 
to an acute challenge (ARS) after 3 weeks of washout (wash). The data, expressed as a percent change 
of No stress/Naïve animals, are the mean ± SEM. *p < 0.05 vs. No stress/No ARS (two-way ANOVA 
with PLSD). 
Moreover, the increased mBDNF levels coupled with the activation of TRKB induced a 
significant enhancement in pERK1/ERK1 (+123%, p < 0.01 vs. No stress/No ARS, Fisher’s PLSD) (CRS: 
F1-16 = 11.902, p < 0.01; ARS: F1-16 = 6.204, p < 0.05, two-way ANOVA) and pERK2/ERK2 (+192%, p < 
0.05 vs. No stress/No ARS, Fisher’s PLSD) (ARS: F1-16 = 4.965, p < 0.05, two-way ANOVA) in the crude 
synaptosomal fraction, of the non-stressed group exposed to restraint stress, a modulation that was 
completely inhibited by the previous exposure to CRS (Figure 5a,b). 
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Figure 5. Analysis of ERK1/2 (panels a,b) (phosphorylated and total) protein levels in the crude 
synaptosomal fraction of the prefrontal cortex of chronically stressed rats (CRS) exposed to an acute 
challenge (ARS) after 3 weeks of washout (wash). The data, expressed as a percent change of No 
stress/Naïve animals, are the mean ± SEM. **p < 0.01 vs. No stress/No ARS (two-way ANOVA with 
PLSD). 
Finally, we did not find any modulation induced by both chronic and acute stressors to the PLCγ 
pathway (Figure 6a,b) in the crude synaptosomal fraction. 
 
Figure 6. Analysis of PLCγ (phosphorylated and total) (panels a,b) protein levels in the crude 
synaptosomal fraction of the prefrontal cortex of chronically stressed rats (CRS) exposed to an acute 
challenge (ARS) after 3 weeks of washout (wash). The data, expressed as a percent change of No 
stress/No ARS animals, are the mean ± SEM. 
3. Discussion 
In this work, we demonstrated that chronic restraint stress produces protracted molecular 
changes that impair the activation of BDNF signaling following a subsequent acute stressor and 
inhibit the ability of PFC to cope with an acute challenge. 
Stress is widely recognized as the major environmental factor causing psychopathologies and, 
in particular, depression [26]. Despite the majority of depressed patients potentially achieving 
remission following successful pharmacological treatment, there is a high percentage of them that 
experience relapse, usually as a consequence of environmental adversities, underlying the need to 
identify novel pharmacological targets to prevent the relapse. 
In this field, the investigation of the role of plasticity in the adult rodent brain in the aftermath 
of chronic stress is growing. 
On these bases, we investigated how chronic stress may affect the ability of the prefrontal cortex 
to react to a subsequent hit in the rest period, in order to identify long-lasting stress-induced changes. 
In line with our previous data [23,24], exposure to chronic stress induced cognitive deficits in 
adult male rats. This negative effect of stress may be responsible for the alteration in the functionality 
of the HPA axis; indeed, we observed that ARS increased the levels of circulating CORT in control 
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animals, a modulation that was inhibited in animals exposed to the challenge following the rest 
period. 
Moreover, after three weeks of washout from stress, the activity-dependent genes Arc and cFos 
were significantly decreased in the PFC of stressed rats, an effect that was previously observed after 
11 days of the chronic restraint protocol [27]. In addition, we found that stress exposure persistently 
reduced Gadd45β expression with respect to control animals, in line with the downregulation of 
Gadd45β in the PFC that has been formerly detected following exposure to the chronic mild 
unpredictable stress protocol [28]. Together, these data suggested that the effect of stress exposure on 
the gene expression of the IEGs was long-lasting. 
However, when we measured their expression following the subsequent exposure to the acute 
challenge, we observed a rapid and strong increase in the IEGs, independently from CRS, indicating 
that the PFC preserves a functional plasticity after the post-stress period, as it adequately reacted to 
a subsequent acute stress exposure in terms of Arc, cFos, and Gadd45β gene expression. In line, the 
PFC is a brain region with high levels of structural and functional plasticity that permits itself to 
modify brain functioning by internalizing behavioral experiences [20]. Accordingly, Moench and 
colleagues demonstrated that elevated platform stress increased cFos expression compared to control 
animals, although this increase was attenuated when the animals were previously exposed to CRS 
[29]. 
With regard to neuroplasticity, it has been effectively demonstrated the dichotomic influence of 
stress on BDNF with the detrimental effect due to chronic exposure [19,30,31], with a positive 
modulation exerted by an acute challenge [22,32–35]. 
Here, we demonstrated that ARS induced an upregulation of mBDNF and of its receptor TRKB 
protein levels, whereas these modulations were completely blunted in rats previously exposed to 
CRS. 
Accordingly, the inability to activate the BDNF-TRKB pathway in stressed animals was reflected 
by the blunted induction of their intracellular-related pathways. Indeed, one hour of acute restraint 
stress upregulated pAKT Ser473 and the downstream effector pS6 Ser240/244 in non-stressed 
animals, as we previously found in rats exposed to 5 min of forced swim stress (FSS) [34]. Moreover, 
acute stress enhanced the protein expression of pERK1/ERK1 and pERK2/ERK2 specifically in control 
animals, as reported by Shen and colleagues following FSS [36], results that were, again, missed in 
stressed rats. By contrast, the PLCγ pathway was not activated by the acute challenge both in non-
stressed and stressed rats, suggesting specificity in the signaling activated by acute restraint stress. 
The observation that the levels of mBDNF and its downstream effectors were similar to non-
stressed animals after 21 days of stress washout was already published by others groups [37,38]. As 
several studies showed that BDNF was reduced immediately after the stress exposure [19,30,31], our 
findings suggested that the modulation of BDNF signaling was returned to baseline after the rest 
period. Accordingly, many studies provide evidence that there is a reversibility in dendritic 
architecture following a period of rest from chronic stress in the PFC and in the Hip [39]. 
However, the failure to activate BDNF cascades in response to acute stress in CRS animals 
indicated that the system is not completely recovered from the effects induced by chronic stress, but 
that some molecular scars, that inhibit the recruitment of the adaptive mechanisms activated in 
healthy subjects, are still present. By note, as we recently demonstrated that ARS induced an 
improvement in the cognitive performance by positively modulating BDNF expression in the PFC 
[22], we could speculate that the inhibition of BDNF signaling in animals previously stressed may 
suggest the persistence of the cognitive deficits in the CRS group. 
Finally, we are aware that this study presents some limitations. First, the molecular analyses 
were conducted at only one time point (one hour) after the ARS, timing that has been chosen on the 
bases of our previous results. Indeed, we recently demonstrated that Bdnf gene expression was 
specifically modulated in the PFC of control animals in the time frame of one hour following ARS 
[22]. Similarly, we decided to deeper investigate the activation of BDNF signaling specifically in the 
PFC, and not in the dorsal and ventral Hip, based on our previous results obtained in this brain region 
after the exposure to the ARS [22], even if it is known that the whole Hip is involved in the modulation 
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of stress response. Lastly, the cognitive task is evaluated by employing only a single behavioral test, 
the novel object recognition test that is, however, widely used to measure working memory, a process 
strictly connected with the PFC [40]. 
4. Materials and Methods 
4.1. Animals 
Adult male Sprague–Dawley rats (Charles River, Calco, Italy) (n = 40) were grouped-housed 
with food and water freely available and were maintained under standard animal facility conditions 
(constant temperature of 22 ± 2 °C, 12 h light/dark cycle, humidity of 50 ± 5%). Animals were 
acclimated for two weeks prior to the starting of the experiment. The experimental protocol has 
conformed to the rules and principles of the 2010/63/UE Directive, and was approved by the Italian 
Health Ministry (authorization n 151/2017-PR). This study research complies with the commonly 
accepted ‘3Rs.’ 
4.2. Stress Procedure and Behavioral Test 
After two weeks of adaptation to the housing conditions, rats were divided into two groups (5–
10 animals for groups): Non-stressed and stressed animals. During the CRS paradigm, stressed rats 
were exposed two times/day for four weeks to one hour of restraint stress at random hours, to avoid 
habituation. After each session of restraint stress, animals were grouped-housed in their home cages. 
The dimensions of the restrainer were similar to the size of the animal, which made the animal almost 
immobile in it. In addition, 24 h after the last stressor, animals were tested in the NOR task as 
previously described [22–24]. Briefly, the test consists of three phases: The encoding phase of 5 min 
with two identical objects in an arena, the consolidation phase of 1 h in the home cage, and the 
retrieval phase of 5 min, in which one of the objects presented previously was replaced by a new one. 
Discrimination index was evaluated according to the formula: Time of novel object minus time of 
familiar object exploration divided by time of novel plus familiar object exploration, multiplied by 
100. After 4 weeks of CRS, animals underwent a period of three weeks of washout from the stress 
procedure and, following this period, rats were exposed to one hour of ARS and sacrificed one hour 
later. The prefrontal cortex, including Cg1, IL, and PrL subregions, (Figure S2) corresponding to 
plates 6–10 of the atlas of Paxinos and Watson [41], was dissected from 2 mm thick slices. 
4.3. Measurement of Plasma Corticosterone Levels 
Trunk blood samples for each rat were collected in tubes with ethylenediaminetetraacetic acid 
and were centrifuged for 20 min at 3000 rcf and 4 °C for the separation of the plasma. An enzyme-
linked immunosorbent assay was employed to determine the corticosterone plasma levels, according 
to the manufacturers’ instructions (IBL international). 
4.4. RNA Preparation and Gene Expression Analysis by Quantitative Real-time PCR 
Total RNA was isolated using PureZol RNA isolation reagent (Bio-Rad Laboratories, Italy) as 
previously reported [42]. The RNA concentrations were measured by spectrophotometry (OD260/280 
1.8 < ratio < 2). The samples (10 ng/µL) were processed for real-time polymerase chain reaction (RT-
PCR) to assess Arc, Gadd45β, and cFos using the iScriptTM one-step RT-PCR kit for probes (Bio-Rad 
Laboratories, Segrate, Italy) and analyzed with the TaqMan qRT PCR CFX384 instrument of Bio-Rad 
Laboratories. Samples were run in 384-well formats in triplicate as multiplexed reactions with the 
36b4 gene as internal control. Primer sequences (Table 2A/B) used were purchased from Eurofins 
MWG-Operon and Life Technologies. 
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Table 2. A-B: Primers and probes purchased from Eurofins MWG-Operon (A) and probes purchased 
from Life Technologies (B). 
A) Forward primer Reverse Primer Probe 
Arc 
GGTGGGTGGCTCTGAAG
AAT 
ACTCCACCCAGTTCTTCAC
C 
GATCCAGAACCACATGAAT
GGG 
cFos TCCTTACGGACTCCCCAC 
CTCCGTTTCTCTTCCTCTTC
AG 
TGCTCTACTTTGCCCCTTCTG
CC 
36b4 
TCAGTGCCTCACTCCATC
AT 
AGGAAGGCCTTGACCTTT
TC 
TGGATACAAAAGGGTCCTGG 
B) Accession number Assay ID  
Gadd45
β BC085337.1 Rn01452530_gI  
Thermal cycling was initiated with an incubation at 50 °C for 10 min (RNA retrotranscription) 
and then at 95 °C for 5 min (TaqMan polymerase activation). After this initial step, 39 cycles of PCR 
were performed. Each PCR cycle consisted of heating the samples at 95 °C for 10 s to enable the 
melting process, and then for 30 s at 60 °C for the annealing and extension reactions. A comparative 
cycle threshold method was used to calculate the relative target gene expression by applying the 2-
∆(∆CT) method [43]. 
4.5. Protein Extraction and Western Blot Analysis 
mBDNF, TRKB, phospho AKT Ser473, AKT, phospho S6Ser240/244, S6, phospho ERK1 Thr202, 
ERK1, phospho ERK2 Tyr204, ERK2, phospho PLCγ Tyr783, and PLCγ protein levels were assessed 
by Western blot analysis. Tissues were manually homogenized and centrifuged to obtain the 
subcellular fractions as previously described [44] (see [32] for the purity of the fraction obtained). The 
Bradford Protein Assay procedure (Bio-Rad Laboratories, Segrate, Italy) was employed to measure 
the total protein content with bovine serum albumin as a calibration standard. In addition, 10 µg of 
protein was run under reducing conditions using Tris-Glycine eXtended precast gels (Bio-Rad 
Laboratories) and then electrophoretically transferred onto nitrocellulose membranes (Bio-Rad 
Laboratories). The membranes were blocked with 10% milk powder and the incubation with the 
primary antibodies (see Table 2) was carried out overnight. Blots were then incubated for 1 h at room 
temperature with the opportune secondary antibody, as summarized in Table 3. 
Immunocomplexes were visualized by chemiluminescence using the Western Lightning Plus 
ECL (PerkinElmer, Milano, Italy) and the Chemidoc MP imaging system (Bio-Rad Laboratories, 
Segrate, Italy). Results were standardized using β-ACTIN as the control protein, which was detected 
by evaluating the band density at 43 kDa. The Western blot bands are reported in Figure S3. 
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Table 3. Antibodies condition used in the Western blot. Milk: M, overnight: O/N, room temperature: 
RT, bovine serum albumin: BSA. 
 Primary Antibody Secondary Antibody 
mBDNF (14kDa) 1:1000 M 3% (Icosagen), 4° O/N Anti-mouse1:3000 M3%, 
1h RT 
TRKB (145–95 kDa) 1:750 M5% (Cell signaling), 4° O/N Anti-rabbit 1:2000 M5%, 1h RT 
TRKB Tyr 706 (145 kDa) 1:500 M5% (Cell signaling), 4° O/N 
Anti-rabbit 1:1000 M5%, 
1h RT 
AKT Ser473 (60 kDa) 1:1000 M5% (Cell signaling), 2h RT Anti-rabbit 1:1000 M5%, 
1h RT 
AKT (60 kDa) 1:1000 M10% (Cell signaling), 4° O/N Anti-rabbit 1:1000 M5%, 
1h RT 
pS6 Ser240/244 (32 kDa) 1:1000 M5% (Cell signaling), 4° O/N 
Anti-rabbit 1:2000 M5%, 
1h RT 
S6 (32 kDa) 1:1000 M5% (Cell signaling), 4° O/N 
Anti-rabbit 1:2000 M5%, 
1h RT 
pERK1/2 Thr202/ Tyr204 
(44 kDa) 
1:1000 M3% (Cell signaling), 4° O/N Anti-rabbit 1:2000 M3%, 
1h RT 
ERK1/2 (44 kDa) 1:1000 M3% (Santa Cruz Biotechnology), 4° O/N 
Anti-rabbit 1:5000 M3%, 
1h RT 
pPLCγ Tyr783 (155 kDa) 1:1000 BSA5% (Cell signaling), 4° O/N Anti-rabbit 1:2000 M5%, 1h RT 
PLCγ (155 kDa) :1000 M5% (Cell signaling), 4° O/N Anti-rabbit 1:1000 M5%, 
1h RT 
β-ACTIN (43 kDa) 1:10000 M3% (Sigma-aldrich), 4° O/N Anti-mouse 1:10000 M3%, 
1h RT 
4.6. Statistical Analyses 
The results of the behavioral test were analyzed with the Unpaired-T test. The effects of the independent factors 
CRS and ARS were analyzed with the two-way analysis of variance (ANOVA: ANALYSIS OF VARIANCE), 
and further differences, when appropriate, were analyzed by Fisher’s protected least significance difference 
(PLSD: protected least significance difference). Significance for both the behavioral and molecular results was 
assumed for p < 0.05. 
5. Conclusions 
In conclusion, the lack of modulation of the BDNF-related cascades induced by ARS in CRS 
animals could indicate a long-lasting effect of chronic stress exposure on mechanisms of synaptic 
plasticity within the PFC, thus underlying how the detrimental consequences of stress may be 
unmasked by the exposure to a second hit. 
These results reveal the complexity of the neuroplastic machinery set in motion to cope with 
challenges, mainly when the system was previously impaired, adding critical new information useful 
for promoting adaptive plasticity and resilience. 
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/21/17/6261/s1. 
Figure S1: Analysis of the cognitive performance in chronically stressed (CRS) rats. The data are the mean ± SEM. 
*p<0.05 vs No stress (Unpaired T-test). Figure S2: Schematic representation of the subregions (Cg1, PrL and IL) 
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